FDA Inspection 1012240 — Excella GmbH & Co. KG
The FDA completed an inspection of Excella GmbH & Co. KG on March 17, 2017 in Feucht. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Feucht (Germany)